Benjamin K. Hanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin K. Hanson has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alexander J. McKeeken
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
25 shared publications - Axia Song
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington
25 shared publications - Cassandra Leibson
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
25 shared publications - Dawei Zong
Molecular Pharmacology and Therapeutics Graduate Program, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota
25 shared publications - Derek L. Stirewalt
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington
25 shared publications - Eirini P. Papapetrou
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
25 shared publications
Latest Publications
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
List of inhibitors for drug screen and IC50 summary
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
List of inhibitors for drug screen and IC50 summary
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S9 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 U2AF1-WT and U2AF1-S34F cells
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 U2AF1-WT and U2AF1-S34F cells
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S7 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 SRSF2-WT and SRSF2-P95H cells
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 SRSF2-WT and SRSF2-P95H cells
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
List of inhibitors for drug screen and IC50 summary
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
List of inhibitors for drug screen and IC50 summary
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S8 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Alternative splicing analysis of K562 SRSF2-WT and SRSF2-P95H cells
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Alternative splicing analysis of K562 SRSF2-WT and SRSF2-P95H cells
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S10 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Alternative splicing analysis of K562 U2AF1-WT and U2AF1-S34F cells
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Alternative splicing analysis of K562 U2AF1-WT and U2AF1-S34F cells
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S9 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 U2AF1-WT and U2AF1-S34F cells
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Differential gene expression of K562 U2AF1-WT and U2AF1-S34F cells
- Open Access
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Table S1 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
- 15 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Table S1 from R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts